| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -36.20M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SYRE returned +512.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +225.1% |
| 1 year | +512.7% |
| 5 years | -41.2% |
| 10 years | -24.5% |
| All-time high | $273.25 (Aug 2018) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in SYRE would be worth today ›No. Spyre Therapeutics, Inc. has not paid a dividend in the past 12 months.
Spyre Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol SYRE.
Spyre Therapeutics, Inc. is part of the Healthcare sector.
Spyre Therapeutics, Inc. has a market cap of 9.39B USD, based on the latest quote.
Spyre Therapeutics, Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
